(Q35871153)

10 August 2017

1 reference

title

Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients (English)

1 reference

10 August 2017

1 reference

Dene Simpson

1

1 reference

PubMed ID

15329045

10 August 2017

Keri Wellington

series ordinal

2

1 reference

10 August 2017

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

64

1 reference

10 August 2017

17

1 reference

10 August 2017

1941-1955

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200464170-00012

10 August 2017

0 references

cites work

Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients

1 reference

12 December 2020

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial

1 reference

12 December 2020

Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.

1 reference

12 December 2020

Nicorandil preserves mitochondrial function during ischemia in perfused rat heart

1 reference

12 December 2020

Rationale and design of a large-scale trial using nicorandil as an adjunct to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction: Japan-Working groups of acute myocardial infarction for the reduction of Necrotic

1 reference

12 December 2020

Comparison of nicorandil and atenolol in stable angina pectoris

1 reference

12 December 2020

Nicorandil, a potent cardioprotective agent, reduces QT dispersion during coronary angioplasty

1 reference

12 December 2020

Antiischemic effects of nicorandil during coronary angioplasty in humans

1 reference

12 December 2020

Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty

1 reference

12 December 2020

Cardioprotective effect of intravenous nicorandil in patients with successful reperfusion for acute myocardial infarction

1 reference

12 December 2020

Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revas

1 reference

12 December 2020

Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy

1 reference

12 December 2020

Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin

1 reference

12 December 2020

A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris

1 reference

12 December 2020

Comparison between nicorandil and magnesium as an adjunct cardioprotective agent to percutaneous coronary intervention in acute anterior myocardial infarction

1 reference

12 December 2020

Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris

1 reference

12 December 2020

KATP channel activation mediates nicorandil-induced relaxation of nitrate-tolerant coronary arteries

1 reference

12 December 2020

Opening of K(ATP) channel attenuates the increase in QT dispersion produced by the first balloon inflation during coronary angioplasty

1 reference

12 December 2020

The effect of K(atp)channel activation on myocardial cationic and energetic status during ischemia and reperfusion: role in cardioprotection

1 reference

12 December 2020

Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs

1 reference

12 December 2020

Nicorandil enhances myocardial tolerance to ischemia without progressive collateral recruitment during coronary angioplasty

1 reference

12 December 2020

Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease.

1 reference

12 December 2020

Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: role of mitochondrial adenosine triphosphate-dependent potassium channels

1 reference

12 December 2020

Pharmacokinetic profile of nicorandil in humans: an overview

1 reference

12 December 2020

Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart.

1 reference

12 December 2020

Noninvasive assessment of the effects of nicorandil on left ventricular volumes and function in reperfused myocardial infarction

1 reference

12 December 2020

Chronic buccal ulceration induced by nicorandil

1 reference

12 December 2020

Investigation and management of stable angina: revised guidelines 1998. Joint Working Party of the British Cardiac Society and Royal College of Physicians of London.

1 reference

12 December 2020

The IONA study: preparing the myocardium for ischaemia?

1 reference

12 December 2020

Protein kinase C-induced changes in the stoichiometry of ATP binding activate cardiac ATP-sensitive K+ channels. A possible mechanistic link to ischemic preconditioning.

1 reference

12 December 2020

Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology

1 reference

12 December 2020

Nicorandil-induced severe oral ulceration: a newly recognized drug reaction

1 reference

12 December 2020

Lack of anti-ischemic efficacy of the potassium channel opener bimakalim in patients with stable angina pectoris

1 reference

12 December 2020

Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure

1 reference

12 December 2020

Nicorandil-induced preconditioning as evidenced by troponin T measurements after coronary angioplasty in patients with stable angina pectoris

1 reference

12 December 2020

Effects of nicorandil on myocardial function and metabolism in the post-ischaemic reperfused heart with or without inhalation anaesthetics

1 reference

12 December 2020

Nicorandil suppressed myocardial purine metabolism during exercise in patients with angina pectoris

1 reference

12 December 2020

Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits

1 reference

12 December 2020

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Pat

1 reference

12 December 2020

Clinical relevance of ischemic preconditioning

1 reference

12 December 2020

Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology

1 reference

12 December 2020

Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes

1 reference

12 December 2020

Nicorandil infusion leads to good recovery from ischemia of left ventricular regional work in comparison with nitroglycerin

1 reference

12 December 2020

Safety profile of nicorandil--prescription-event monitoring (PEM) study

1 reference

12 December 2020

Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C.

1 reference

12 December 2020

Trial to show the impact of nicorandil in angina (IONA): design, methodology, and management

1 reference

12 December 2020

Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.

1 reference

12 December 2020

Evidence of pharmacologic preconditioning during PTCA by intravenous pretreatment with ATP-sensitive K+ channel opener nicorandil

1 reference

12 December 2020

Effects of nicorandil on endogenous fibrinolytic capacity in patients with coronary artery disease

1 reference

12 December 2020

The role of ATP-sensitive potassium channels in the mechanism of ischemic preconditioning

1 reference

12 December 2020

Nicorandil associated anal ulceration

1 reference

12 December 2020

Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation

1 reference

12 December 2020

Highly protective effects of chronic oral administration of nicorandil on the heart of ageing rats

1 reference

12 December 2020

Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study

1 reference

12 December 2020

Selected issues from an overview on nicorandil: tolerance, duration of action, and long-term efficacy

1 reference

12 December 2020

Combination of miglitol, an anti-diabetic drug, and nicorandil markedly reduces myocardial infarct size through opening the mitochondrial K(ATP) channels in rabbits

1 reference

12 December 2020

Role of nicorandil in ischaemic preconditioning

1 reference

12 December 2020

Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction

1 reference

12 December 2020

Nicorandil, a hybrid between nitrate and ATP-sensitive potassium channel opener, preconditions human heart to ischemia during percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil

1 reference

12 December 2020

Nicorandil safety in the long-term treatment of coronary heart disease

1 reference

12 December 2020

Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction

1 reference

12 December 2020

Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study

1 reference

12 December 2020

Preconditioning protects by inhibiting the mitochondrial permeability transition

1 reference

12 December 2020

Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects

1 reference

12 December 2020

Nicorandil affords cardioprotection in patients with acute myocardial infarction treated with primary percutaneous transluminal coronary angioplasty: assessment with thallium-201/iodine-123 BMIPP dual SPECT

1 reference

12 December 2020

Safety profile of an anti-anginal agent with potassium channel opening activity: an overview

1 reference

12 December 2020

Chronic anal ulceration due to nicorandil

1 reference

12 December 2020

Nicorandil attenuates the mitochondrial Ca2+ overload with accompanying depolarization of the mitochondrial membrane in the heart

1 reference

12 December 2020

Effect of ischemic preconditioning and mitochondrial KATP channel openers on chronic left ventricular remodeling in the ischemic-reperfused rat heart

1 reference

12 December 2020

A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris

1 reference

12 December 2020

Giant oral aphthous ulcers induced by nicorandil

1 reference

12 December 2020

Nicorandil-associated anal ulceration

1 reference

12 December 2020

Nicorandil inhibits oxidative stress-induced apoptosis in cardiac myocytes through activation of mitochondrial ATP-sensitive potassium channels and a nitrate-like effect

1 reference

12 December 2020

Comparison of tolerance to intravenous nitroglycerin during nicorandil and intermittent nitroglycerin patch in healthy volunteers.

1 reference

12 December 2020

Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction

1 reference

12 December 2020

Effect of nicorandil on post-ischaemic contractile dysfunction in the heart: roles of its ATP-sensitive K+ channel opening property and nitrate property

1 reference

12 December 2020

A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina

1 reference

12 December 2020

Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo.

1 reference

12 December 2020

Role of nicorandil in ischaemic preconditioning

1 reference

12 December 2020

Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure

1 reference

12 December 2020

Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels.

1 reference

12 December 2020

Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits

1 reference

12 December 2020

10.2165/00003495-200464170-00012

Identifiers

DOI

1 reference

PubMed ID

15329045

Dimensions Publication ID

10 August 2017

0 references

1 reference

PubMed ID

15329045